Global Nail Psoriasis Treatment Supply, Demand and Key Producers, 2026-2032

March 2026 | 75 pages | ID: G492ABD5A730EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Nail Psoriasis Treatment market size is expected to reach $ 1051 million by 2032, rising at a market growth of 7.4% CAGR during the forecast period (2026-2032).

Nail psoriasis treatment refers to a comprehensive management approach targeting psoriatic involvement of the nail unit?nail plate, nail bed, nail matrix, and periungual tissue?manifesting as pitting, onycholysis, subungual hyperkeratosis, discoloration, and crumbling. The goals are to reduce inflammation, restore nail structure and appearance, relieve pain and functional limitation, and mitigate relapse and complication risks. Therapeutic strategies are inherently ?local plus systemic?: limited nail involvement is often managed with topical therapies, occlusion approaches, and selected intralesional procedures; more extensive nail disease, concomitant moderate-to-severe skin psoriasis, or elevated psoriatic arthritis risk frequently warrants systemic therapy (conventional systemics, small molecules, and/or biologics) with longitudinal follow-up.The average gross profit margin of this product is 55%.

Nail involvement is associated with higher disease burden and quality-of-life impairment and is often viewed as a clinically meaningful ?high-impact? domain, strengthening patient demand for visible improvement and pushing dermatology care toward more refined, site-specific management. In parallel, maturation of biologic and systemic care pathways and wider adoption of standardized follow-up frameworks reinforce a credible clinical and reimbursement narrative?shifting nail psoriasis from a historically difficult-to-treat area toward measurable, sustainable improvement and expanding specialty-care demand. Responses are slow and heterogeneous, and matrix- vs bed-dominant disease requires different delivery approaches; without structured phenotyping and standardized protocols, outcomes can be inconsistent and adherence can erode. Topicals and intralesional procedures face operational and tolerability barriers, while systemic therapy introduces long-term monitoring, comedication complexity, and cost constraints?creating real-world sustainability hurdles. Additional risks include delayed diagnosis due to confounders (e.g., co-existing onychomycosis) and access variability driven by regional guideline, reimbursement, and prescribing restrictions. Demand is moving from ?single-agent trials? to stratified combination strategies: limited nail involvement increasingly prioritizes high-efficacy topical regimens (often steroid plus vitamin D analog) and site-specific protocols for matrix vs bed disease, with intralesional options used when higher targeting is needed; broader disease more often favors systemic therapy to capture integrated benefits across skin, nails, and joint-risk management. Rising expectations for speed of improvement, cosmetic recovery, and durable maintenance are also accelerating adoption of more user-friendly delivery formats (penetration-enhanced vehicles, occlusive systems, home-usable regimens) and digital follow-up tools to support adherence. ?Upstream? in this space is primarily defined by drug and delivery-platform capabilities. Topical products rely on high-purity actives and stable vehicles engineered for nail-unit barrier challenges (penetration enhancement, film-forming/occlusion, controlled release, and low-irritancy excipients). Intralesional approaches require sterile formulations with controlled physicochemical properties and compatible devices. Systemic therapy depends on robust upstream raw materials, process consistency, and quality systems (and, for biologics, cold-chain readiness). As evidence expectations rise for high-impact domains, capabilities in endpoint design, real-world data quality, and pharmacovigilance are increasingly treated as upstream determinants of competitiveness and access efficiency.

This report studies the global Nail Psoriasis Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nail Psoriasis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nail Psoriasis Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Nail Psoriasis Treatment total market, 2021-2032, (USD Million)
Global Nail Psoriasis Treatment total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nail Psoriasis Treatment total market, key domestic companies, and share, (USD Million)
Global Nail Psoriasis Treatment revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nail Psoriasis Treatment total market by Type, CAGR, 2021-2032, (USD Million)
Global Nail Psoriasis Treatment total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Nail Psoriasis Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Pfizer, Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nail Psoriasis Treatment market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Nail Psoriasis Treatment Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Nail Psoriasis Treatment Market, Segmentation by Type:
  • Topical Corticosteroids
  • Vitamin D Analogues
  • Systemic Biologics
  • Small-molecule Inhibitors
Global Nail Psoriasis Treatment Market, Segmentation by Sales Channel:
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
Global Nail Psoriasis Treatment Market, Segmentation by Route of Administration:
  • Topical
  • Oral
Global Nail Psoriasis Treatment Market, Segmentation by Application:
  • Dermatology Clinics
  • Hospital
  • Other
Companies Profiled:
  • AbbVie
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Eli Lilly
Key Questions Answered
1. How big is the global Nail Psoriasis Treatment market?
2. What is the demand of the global Nail Psoriasis Treatment market?
3. What is the year over year growth of the global Nail Psoriasis Treatment market?
4. What is the total value of the global Nail Psoriasis Treatment market?
5. Who are the Major Players in the global Nail Psoriasis Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Nail Psoriasis Treatment Introduction
1.2 World Nail Psoriasis Treatment Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Nail Psoriasis Treatment Total Market by Region (by Headquarter Location)
  1.3.1 World Nail Psoriasis Treatment Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Nail Psoriasis Treatment Revenue (2021-2032)
  1.3.3 China Based Company Nail Psoriasis Treatment Revenue (2021-2032)
  1.3.4 Europe Based Company Nail Psoriasis Treatment Revenue (2021-2032)
  1.3.5 Japan Based Company Nail Psoriasis Treatment Revenue (2021-2032)
  1.3.6 South Korea Based Company Nail Psoriasis Treatment Revenue (2021-2032)
  1.3.7 ASEAN Based Company Nail Psoriasis Treatment Revenue (2021-2032)
  1.3.8 India Based Company Nail Psoriasis Treatment Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Nail Psoriasis Treatment Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Nail Psoriasis Treatment Consumption Value (2021-2032)
2.2 World Nail Psoriasis Treatment Consumption Value by Region
  2.2.1 World Nail Psoriasis Treatment Consumption Value by Region (2021-2026)
  2.2.2 World Nail Psoriasis Treatment Consumption Value Forecast by Region (2027-2032)
2.3 United States Nail Psoriasis Treatment Consumption Value (2021-2032)
2.4 China Nail Psoriasis Treatment Consumption Value (2021-2032)
2.5 Europe Nail Psoriasis Treatment Consumption Value (2021-2032)
2.6 Japan Nail Psoriasis Treatment Consumption Value (2021-2032)
2.7 South Korea Nail Psoriasis Treatment Consumption Value (2021-2032)
2.8 ASEAN Nail Psoriasis Treatment Consumption Value (2021-2032)
2.9 India Nail Psoriasis Treatment Consumption Value (2021-2032)

3 WORLD NAIL PSORIASIS TREATMENT COMPANIES COMPETITIVE ANALYSIS

3.1 World Nail Psoriasis Treatment Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Nail Psoriasis Treatment Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Nail Psoriasis Treatment in 2025
  3.2.3 Global Concentration Ratios (CR8) for Nail Psoriasis Treatment in 2025
3.3 Nail Psoriasis Treatment Company Evaluation Quadrant
3.4 Nail Psoriasis Treatment Market: Overall Company Footprint Analysis
  3.4.1 Nail Psoriasis Treatment Market: Region Footprint
  3.4.2 Nail Psoriasis Treatment Market: Company Product Type Footprint
  3.4.3 Nail Psoriasis Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Nail Psoriasis Treatment Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Nail Psoriasis Treatment Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Nail Psoriasis Treatment Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Nail Psoriasis Treatment Consumption Value Comparison
  4.2.1 United States VS China: Nail Psoriasis Treatment Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Nail Psoriasis Treatment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Nail Psoriasis Treatment Companies and Market Share, 2021-2026
  4.3.1 United States Based Nail Psoriasis Treatment Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Nail Psoriasis Treatment Revenue, (2021-2026)
4.4 China Based Companies Nail Psoriasis Treatment Revenue and Market Share, 2021-2026
  4.4.1 China Based Nail Psoriasis Treatment Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Nail Psoriasis Treatment Revenue, (2021-2026)
4.5 Rest of World Based Nail Psoriasis Treatment Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Nail Psoriasis Treatment Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Nail Psoriasis Treatment Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Nail Psoriasis Treatment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Topical Corticosteroids
  5.2.2 Vitamin D Analogues
  5.2.3 Systemic Biologics
  5.2.4 Small-molecule Inhibitors
5.3 Market Segment by Type
  5.3.1 World Nail Psoriasis Treatment Market Size by Type (2021-2026)
  5.3.2 World Nail Psoriasis Treatment Market Size by Type (2027-2032)
  5.3.3 World Nail Psoriasis Treatment Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY SALES CHANNEL

6.1 World Nail Psoriasis Treatment Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channel
  6.2.1 Retail Pharmacies
  6.2.2 Hospital Pharmacies
  6.2.3 Online Pharmacies
6.3 Market Segment by Sales Channel
  6.3.1 World Nail Psoriasis Treatment Market Size by Sales Channel (2021-2026)
  6.3.2 World Nail Psoriasis Treatment Market Size by Sales Channel (2027-2032)
  6.3.3 World Nail Psoriasis Treatment Market Size Market Share by Sales Channel (2027-2032)

7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1 World Nail Psoriasis Treatment Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
  7.2.1 Topical
  7.2.2 Oral
7.3 Market Segment by Route of Administration
  7.3.1 World Nail Psoriasis Treatment Market Size by Route of Administration (2021-2026)
  7.3.2 World Nail Psoriasis Treatment Market Size by Route of Administration (2027-2032)
  7.3.3 World Nail Psoriasis Treatment Market Size Market Share by Route of Administration (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Nail Psoriasis Treatment Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Dermatology Clinics
  8.2.2 Hospital
  8.2.3 Other
8.3 Market Segment by Application
  8.3.1 World Nail Psoriasis Treatment Market Size by Application (2021-2026)
  8.3.2 World Nail Psoriasis Treatment Market Size by Application (2027-2032)
  8.3.3 World Nail Psoriasis Treatment Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 AbbVie
  9.1.1 AbbVie Details
  9.1.2 AbbVie Major Business
  9.1.3 AbbVie Nail Psoriasis Treatment Product and Services
  9.1.4 AbbVie Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 AbbVie Recent Developments/Updates
  9.1.6 AbbVie Competitive Strengths & Weaknesses
9.2 Johnson & Johnson
  9.2.1 Johnson & Johnson Details
  9.2.2 Johnson & Johnson Major Business
  9.2.3 Johnson & Johnson Nail Psoriasis Treatment Product and Services
  9.2.4 Johnson & Johnson Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 Johnson & Johnson Recent Developments/Updates
  9.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.3 Novartis
  9.3.1 Novartis Details
  9.3.2 Novartis Major Business
  9.3.3 Novartis Nail Psoriasis Treatment Product and Services
  9.3.4 Novartis Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 Novartis Recent Developments/Updates
  9.3.6 Novartis Competitive Strengths & Weaknesses
9.4 Pfizer
  9.4.1 Pfizer Details
  9.4.2 Pfizer Major Business
  9.4.3 Pfizer Nail Psoriasis Treatment Product and Services
  9.4.4 Pfizer Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 Pfizer Recent Developments/Updates
  9.4.6 Pfizer Competitive Strengths & Weaknesses
9.5 Eli Lilly
  9.5.1 Eli Lilly Details
  9.5.2 Eli Lilly Major Business
  9.5.3 Eli Lilly Nail Psoriasis Treatment Product and Services
  9.5.4 Eli Lilly Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 Eli Lilly Recent Developments/Updates
  9.5.6 Eli Lilly Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Nail Psoriasis Treatment Industry Chain
10.2 Nail Psoriasis Treatment Upstream Analysis
10.3 Nail Psoriasis Treatment Midstream Analysis
10.4 Nail Psoriasis Treatment Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer


LIST OF TABLES

Table 1. World Nail Psoriasis Treatment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Nail Psoriasis Treatment Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Nail Psoriasis Treatment Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Nail Psoriasis Treatment Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Nail Psoriasis Treatment Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Nail Psoriasis Treatment Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Nail Psoriasis Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Nail Psoriasis Treatment Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Nail Psoriasis Treatment Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Nail Psoriasis Treatment Players in 2025
Table 12. World Nail Psoriasis Treatment Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Nail Psoriasis Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Nail Psoriasis Treatment Players
Table 15. Nail Psoriasis Treatment Market: Company Product Type Footprint
Table 16. Nail Psoriasis Treatment Market: Company Product Application Footprint
Table 17. Nail Psoriasis Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Nail Psoriasis Treatment Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Nail Psoriasis Treatment Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Nail Psoriasis Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Nail Psoriasis Treatment Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Nail Psoriasis Treatment Revenue Market Share (2021-2026)
Table 23. China Based Nail Psoriasis Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Nail Psoriasis Treatment Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Nail Psoriasis Treatment Revenue Market Share (2021-2026)
Table 26. Rest of World Based Nail Psoriasis Treatment Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Nail Psoriasis Treatment Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Nail Psoriasis Treatment Revenue Market Share (2021-2026)
Table 29. World Nail Psoriasis Treatment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Nail Psoriasis Treatment Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Nail Psoriasis Treatment Market Size by Type (2027-2032) & (USD Million)
Table 32. World Nail Psoriasis Treatment Market Size by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 33. World Nail Psoriasis Treatment Market Size Value by Sales Channel (2021-2026) & (USD Million)
Table 34. World Nail Psoriasis Treatment Market Size by Sales Channel (2027-2032) & (USD Million)
Table 35. World Nail Psoriasis Treatment Market Size by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 36. World Nail Psoriasis Treatment Market Size Value by Route of Administration (2021-2026) & (USD Million)
Table 37. World Nail Psoriasis Treatment Market Size by Route of Administration (2027-2032) & (USD Million)
Table 38. World Nail Psoriasis Treatment Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Nail Psoriasis Treatment Market Size by Application (2021-2026) & (USD Million)
Table 40. World Nail Psoriasis Treatment Market Size by Application (2027-2032) & (USD Million)
Table 41. AbbVie Basic Information, Manufacturing Base and Competitors
Table 42. AbbVie Major Business
Table 43. AbbVie Nail Psoriasis Treatment Product and Services
Table 44. AbbVie Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. AbbVie Recent Developments/Updates
Table 46. AbbVie Competitive Strengths & Weaknesses
Table 47. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 48. Johnson & Johnson Major Business
Table 49. Johnson & Johnson Nail Psoriasis Treatment Product and Services
Table 50. Johnson & Johnson Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Johnson & Johnson Recent Developments/Updates
Table 52. Johnson & Johnson Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Nail Psoriasis Treatment Product and Services
Table 56. Novartis Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Pfizer Basic Information, Manufacturing Base and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer Nail Psoriasis Treatment Product and Services
Table 62. Pfizer Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Pfizer Recent Developments/Updates
Table 64. Pfizer Competitive Strengths & Weaknesses
Table 65. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 66. Eli Lilly Major Business
Table 67. Eli Lilly Nail Psoriasis Treatment Product and Services
Table 68. Eli Lilly Nail Psoriasis Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Eli Lilly Recent Developments/Updates
Table 70. Eli Lilly Competitive Strengths & Weaknesses
Table 71. Global Key Players of Nail Psoriasis Treatment Upstream (Raw Materials)
Table 72. Global Nail Psoriasis Treatment Typical Customers

LIST OF FIGURES

Figure 1. Nail Psoriasis Treatment Picture
Figure 2. World Nail Psoriasis Treatment Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Nail Psoriasis Treatment Total Revenue (2021-2032) & (USD Million)
Figure 4. World Nail Psoriasis Treatment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Nail Psoriasis Treatment Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Nail Psoriasis Treatment Revenue (2021-2032) & (USD Million)
Figure 13. Nail Psoriasis Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 16. World Nail Psoriasis Treatment Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 18. China Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 23. India Nail Psoriasis Treatment Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Nail Psoriasis Treatment by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Nail Psoriasis Treatment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Nail Psoriasis Treatment Markets in 2025
Figure 27. United States VS China: Nail Psoriasis Treatment Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Nail Psoriasis Treatment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Nail Psoriasis Treatment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Nail Psoriasis Treatment Market Size Market Share by Type in 2025
Figure 31. Topical Corticosteroids
Figure 32. Vitamin D Analogues
Figure 33. Systemic Biologics
Figure 34. Small-molecule Inhibitors
Figure 35. World Nail Psoriasis Treatment Market Size Market Share by Type (2021-2032)
Figure 36. World Nail Psoriasis Treatment Market Size by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 37. World Nail Psoriasis Treatment Market Size Market Share by Sales Channel in 2025
Figure 38. Retail Pharmacies
Figure 39. Hospital Pharmacies
Figure 40. Online Pharmacies
Figure 41. World Nail Psoriasis Treatment Market Size Market Share by Sales Channel (2021-2032)
Figure 42. World Nail Psoriasis Treatment Market Size by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 43. World Nail Psoriasis Treatment Market Size Market Share by Route of Administration in 2025
Figure 44. Topical
Figure 45. Oral
Figure 46. World Nail Psoriasis Treatment Market Size Market Share by Route of Administration (2021-2032)
Figure 47. World Nail Psoriasis Treatment Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Nail Psoriasis Treatment Market Size Market Share by Application in 2025
Figure 49. Dermatology Clinics
Figure 50. Hospital
Figure 51. Other
Figure 52. World Nail Psoriasis Treatment Market Size Market Share by Application (2021-2032)
Figure 53. Nail Psoriasis Treatment Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source


More Publications